Erasca Stock 715%. Here’s Why One Biotech Fund Still Bets More
A major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...
Market cap weighting tends to allocate more to larger firms, influencing risk and return. This intro outlines the rationale and implications.
28,489 articlesA major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...
Palantir stock slipped from its peak, triggering questions about value, risk, and timing for late 2026. This guide br...
As markets shift in 2026, dividend-focused funds regain attention. This guide breaks down the ishares core high divid...
A sharp jump in a small card issuer’s shares grabbed headlines. This article breaks down why card group stock popped,...
BIT Capital trimmed a large Lemonade stake in the first quarter, revealing how institutional moves can influence vola...
Silver prices have surged, lifting miners' profits and spurring a new wave of income-focused ETFs. Three TSX-listed f...
The memory ETF DRAM fell 15% in one day as a guidance miss sparked a broader selloff, underscoring the risk of a conc...
A recent insider move at Lindblad Expeditions Holdings drew attention from investors. This article breaks down what h...
If you missed Nvidia's historic run, you're not out of luck. This article outlines two solid AI-focused winners at di...
Dua Lipa’s London wedding offered a modern twist on bridal fashion, mixing luxury tailoring with budget-smart choices...
Microsoft just 1-year low has triggered a wave of questions for investors. This guide breaks down what happened, why ...
As Nvidia's earnings hours away approach, investors crave clarity on AI demand, profitability, and guidance. This pie...